Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol
[Display omitted] 2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid in the brain and an agonist at two cannabinoid receptors (CB1 and CB2). The synthesis, degradation and signaling of 2-AG have been investigated in detail but its relationship to other endogenous monoacylglyce...
Gespeichert in:
Veröffentlicht in: | Pharmacological research 2016-08, Vol.110, p.173-180 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 180 |
---|---|
container_issue | |
container_start_page | 173 |
container_title | Pharmacological research |
container_volume | 110 |
creator | Murataeva, Natalia Dhopeshwarkar, Amey Yin, Danielle Mitjavila, José Bradshaw, Heather Straiker, Alex Mackie, Ken |
description | [Display omitted]
2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid in the brain and an agonist at two cannabinoid receptors (CB1 and CB2). The synthesis, degradation and signaling of 2-AG have been investigated in detail but its relationship to other endogenous monoacylglycerols has not been fully explored. Three congeners that have been isolated from the CNS are 2-linoleoylglycerol (2-LG), 2-oleoylglycerol (2-OG), and 2-palmitoylglycerol (2-PG). These lipids do not orthosterically bind to cannabinoid receptors but are reported to potentiate the activity of 2-AG, possibly through inhibition of 2-AG degradation. This phenomenon has been dubbed the ‘entourage effect’ and has been proposed to regulate synaptic activity of 2-AG. To clarify the activity of these congeners of 2-AG we tested them in neuronal and cell-based signaling assays.
The signaling profile for these compounds is inconsistent with an entourage effect. None of the compounds inhibited neurotransmission via CB1 in autaptic neurons. Interestingly, each failed to potentiate 2-AG-mediated depolarization-induced suppression of excitation (DSE), behaving instead as antagonists. Examining other signaling pathways we found that 2-OG interferes with agonist-induced CB1 internalization while 2-PG modestly internalizes CB1 receptors. However in tests of pERK, cAMP and arrestin recruitment, none of the acylglycerols altered CB1 signaling.
Our results suggest 1) that these compounds do not serve as entourage compounds under the conditions examined, and 2) that they may instead serve as functional antagonists. Our results suggest that the relationship between 2-AG and its congeners is more nuanced than previously appreciated. |
doi_str_mv | 10.1016/j.phrs.2016.04.015 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5108301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043661816303346</els_id><sourcerecordid>1798721288</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-2da649cdd0c30090029a83355f10831fd5ace32c9860230f9eea13c9050cc5463</originalsourceid><addsrcrecordid>eNp9UU1r3DAQFaGlSZP-gRyCjz3U7oxkyzaEhhL6BYFeEnoUqjze1Ua2tpId2Fv_Rv9ef0llNgnJpScN7715M5rH2ClCgYDy_abYrkMseKoLKAvA6oAdIbQyR2zki6UuRS4lNofsdYwbAGhLhFfskNeItZT1Ebv9saZAf3__idmwy2ic_Bz0ii6y6zVlZg7WzzEzOlLm-4zn3pHfuZXbGQrevUuIs2MCx2eoHrvEbLUb7PSEOGEve-0ivbl_j9nN50_Xl1_zq-9fvl1-vMpNxXHKeadl2ZquAyPSxgC81Y0QVdUjNAL7rtKGBDdtI4EL6FsijcK0UIExVSnFMfuw993OPwfqTPpV0E5tgx102CmvrXrOjHatVv5OVcsAwGTw9t4g-F8zxUkNNhpyTo-U7qGwbpuaI2-aJOV7qQk-xkD94xgEtaSkNmpJSS0pKShVSik1nT1d8LHlIZYkON8LKJ3pzlJQ0VgaDXU2kJlU5-3__P8BhjumWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1798721288</pqid></control><display><type>article</type><title>Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Murataeva, Natalia ; Dhopeshwarkar, Amey ; Yin, Danielle ; Mitjavila, José ; Bradshaw, Heather ; Straiker, Alex ; Mackie, Ken</creator><creatorcontrib>Murataeva, Natalia ; Dhopeshwarkar, Amey ; Yin, Danielle ; Mitjavila, José ; Bradshaw, Heather ; Straiker, Alex ; Mackie, Ken</creatorcontrib><description>[Display omitted]
2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid in the brain and an agonist at two cannabinoid receptors (CB1 and CB2). The synthesis, degradation and signaling of 2-AG have been investigated in detail but its relationship to other endogenous monoacylglycerols has not been fully explored. Three congeners that have been isolated from the CNS are 2-linoleoylglycerol (2-LG), 2-oleoylglycerol (2-OG), and 2-palmitoylglycerol (2-PG). These lipids do not orthosterically bind to cannabinoid receptors but are reported to potentiate the activity of 2-AG, possibly through inhibition of 2-AG degradation. This phenomenon has been dubbed the ‘entourage effect’ and has been proposed to regulate synaptic activity of 2-AG. To clarify the activity of these congeners of 2-AG we tested them in neuronal and cell-based signaling assays.
The signaling profile for these compounds is inconsistent with an entourage effect. None of the compounds inhibited neurotransmission via CB1 in autaptic neurons. Interestingly, each failed to potentiate 2-AG-mediated depolarization-induced suppression of excitation (DSE), behaving instead as antagonists. Examining other signaling pathways we found that 2-OG interferes with agonist-induced CB1 internalization while 2-PG modestly internalizes CB1 receptors. However in tests of pERK, cAMP and arrestin recruitment, none of the acylglycerols altered CB1 signaling.
Our results suggest 1) that these compounds do not serve as entourage compounds under the conditions examined, and 2) that they may instead serve as functional antagonists. Our results suggest that the relationship between 2-AG and its congeners is more nuanced than previously appreciated.</description><identifier>ISSN: 1043-6618</identifier><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1016/j.phrs.2016.04.015</identifier><identifier>PMID: 27117667</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>2-AG ; 2-Arachidonoylglycerol ; 2-LG ; 2-Linolenoylglycerol ; 2-OG ; 2-Oleoylglycerol ; 2-Palmitoyglycerol ; 2-PG ; Acylglycerol ; Animals ; Arrestin - metabolism ; Cannabinoid ; Cannabinoid Receptor Antagonists - metabolism ; Cannabinoid Receptor Antagonists - pharmacology ; CB1 ; Cell Line ; Congener ; Cyclic AMP - metabolism ; Dose-Response Relationship, Drug ; Endocannabinoids - metabolism ; Endocannabinoids - pharmacology ; Entourage ; Extracellular Signal-Regulated MAP Kinases - metabolism ; Glycerides - metabolism ; Glycerides - pharmacology ; Hippocampus - cytology ; Hippocampus - drug effects ; Hippocampus - metabolism ; Humans ; Mice ; Neurons - drug effects ; Neurons - metabolism ; Phosphorylation ; Receptor, Cannabinoid, CB1 - antagonists & inhibitors ; Receptor, Cannabinoid, CB1 - genetics ; Receptor, Cannabinoid, CB1 - metabolism ; Synaptic Transmission - drug effects ; Time Factors ; Transfection</subject><ispartof>Pharmacological research, 2016-08, Vol.110, p.173-180</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-2da649cdd0c30090029a83355f10831fd5ace32c9860230f9eea13c9050cc5463</citedby><cites>FETCH-LOGICAL-c521t-2da649cdd0c30090029a83355f10831fd5ace32c9860230f9eea13c9050cc5463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1043661816303346$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27117667$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murataeva, Natalia</creatorcontrib><creatorcontrib>Dhopeshwarkar, Amey</creatorcontrib><creatorcontrib>Yin, Danielle</creatorcontrib><creatorcontrib>Mitjavila, José</creatorcontrib><creatorcontrib>Bradshaw, Heather</creatorcontrib><creatorcontrib>Straiker, Alex</creatorcontrib><creatorcontrib>Mackie, Ken</creatorcontrib><title>Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>[Display omitted]
2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid in the brain and an agonist at two cannabinoid receptors (CB1 and CB2). The synthesis, degradation and signaling of 2-AG have been investigated in detail but its relationship to other endogenous monoacylglycerols has not been fully explored. Three congeners that have been isolated from the CNS are 2-linoleoylglycerol (2-LG), 2-oleoylglycerol (2-OG), and 2-palmitoylglycerol (2-PG). These lipids do not orthosterically bind to cannabinoid receptors but are reported to potentiate the activity of 2-AG, possibly through inhibition of 2-AG degradation. This phenomenon has been dubbed the ‘entourage effect’ and has been proposed to regulate synaptic activity of 2-AG. To clarify the activity of these congeners of 2-AG we tested them in neuronal and cell-based signaling assays.
The signaling profile for these compounds is inconsistent with an entourage effect. None of the compounds inhibited neurotransmission via CB1 in autaptic neurons. Interestingly, each failed to potentiate 2-AG-mediated depolarization-induced suppression of excitation (DSE), behaving instead as antagonists. Examining other signaling pathways we found that 2-OG interferes with agonist-induced CB1 internalization while 2-PG modestly internalizes CB1 receptors. However in tests of pERK, cAMP and arrestin recruitment, none of the acylglycerols altered CB1 signaling.
Our results suggest 1) that these compounds do not serve as entourage compounds under the conditions examined, and 2) that they may instead serve as functional antagonists. Our results suggest that the relationship between 2-AG and its congeners is more nuanced than previously appreciated.</description><subject>2-AG</subject><subject>2-Arachidonoylglycerol</subject><subject>2-LG</subject><subject>2-Linolenoylglycerol</subject><subject>2-OG</subject><subject>2-Oleoylglycerol</subject><subject>2-Palmitoyglycerol</subject><subject>2-PG</subject><subject>Acylglycerol</subject><subject>Animals</subject><subject>Arrestin - metabolism</subject><subject>Cannabinoid</subject><subject>Cannabinoid Receptor Antagonists - metabolism</subject><subject>Cannabinoid Receptor Antagonists - pharmacology</subject><subject>CB1</subject><subject>Cell Line</subject><subject>Congener</subject><subject>Cyclic AMP - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Endocannabinoids - metabolism</subject><subject>Endocannabinoids - pharmacology</subject><subject>Entourage</subject><subject>Extracellular Signal-Regulated MAP Kinases - metabolism</subject><subject>Glycerides - metabolism</subject><subject>Glycerides - pharmacology</subject><subject>Hippocampus - cytology</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Humans</subject><subject>Mice</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Phosphorylation</subject><subject>Receptor, Cannabinoid, CB1 - antagonists & inhibitors</subject><subject>Receptor, Cannabinoid, CB1 - genetics</subject><subject>Receptor, Cannabinoid, CB1 - metabolism</subject><subject>Synaptic Transmission - drug effects</subject><subject>Time Factors</subject><subject>Transfection</subject><issn>1043-6618</issn><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU1r3DAQFaGlSZP-gRyCjz3U7oxkyzaEhhL6BYFeEnoUqjze1Ua2tpId2Fv_Rv9ef0llNgnJpScN7715M5rH2ClCgYDy_abYrkMseKoLKAvA6oAdIbQyR2zki6UuRS4lNofsdYwbAGhLhFfskNeItZT1Ebv9saZAf3__idmwy2ic_Bz0ii6y6zVlZg7WzzEzOlLm-4zn3pHfuZXbGQrevUuIs2MCx2eoHrvEbLUb7PSEOGEve-0ivbl_j9nN50_Xl1_zq-9fvl1-vMpNxXHKeadl2ZquAyPSxgC81Y0QVdUjNAL7rtKGBDdtI4EL6FsijcK0UIExVSnFMfuw993OPwfqTPpV0E5tgx102CmvrXrOjHatVv5OVcsAwGTw9t4g-F8zxUkNNhpyTo-U7qGwbpuaI2-aJOV7qQk-xkD94xgEtaSkNmpJSS0pKShVSik1nT1d8LHlIZYkON8LKJ3pzlJQ0VgaDXU2kJlU5-3__P8BhjumWA</recordid><startdate>20160801</startdate><enddate>20160801</enddate><creator>Murataeva, Natalia</creator><creator>Dhopeshwarkar, Amey</creator><creator>Yin, Danielle</creator><creator>Mitjavila, José</creator><creator>Bradshaw, Heather</creator><creator>Straiker, Alex</creator><creator>Mackie, Ken</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160801</creationdate><title>Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol</title><author>Murataeva, Natalia ; Dhopeshwarkar, Amey ; Yin, Danielle ; Mitjavila, José ; Bradshaw, Heather ; Straiker, Alex ; Mackie, Ken</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-2da649cdd0c30090029a83355f10831fd5ace32c9860230f9eea13c9050cc5463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>2-AG</topic><topic>2-Arachidonoylglycerol</topic><topic>2-LG</topic><topic>2-Linolenoylglycerol</topic><topic>2-OG</topic><topic>2-Oleoylglycerol</topic><topic>2-Palmitoyglycerol</topic><topic>2-PG</topic><topic>Acylglycerol</topic><topic>Animals</topic><topic>Arrestin - metabolism</topic><topic>Cannabinoid</topic><topic>Cannabinoid Receptor Antagonists - metabolism</topic><topic>Cannabinoid Receptor Antagonists - pharmacology</topic><topic>CB1</topic><topic>Cell Line</topic><topic>Congener</topic><topic>Cyclic AMP - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Endocannabinoids - metabolism</topic><topic>Endocannabinoids - pharmacology</topic><topic>Entourage</topic><topic>Extracellular Signal-Regulated MAP Kinases - metabolism</topic><topic>Glycerides - metabolism</topic><topic>Glycerides - pharmacology</topic><topic>Hippocampus - cytology</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Humans</topic><topic>Mice</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Phosphorylation</topic><topic>Receptor, Cannabinoid, CB1 - antagonists & inhibitors</topic><topic>Receptor, Cannabinoid, CB1 - genetics</topic><topic>Receptor, Cannabinoid, CB1 - metabolism</topic><topic>Synaptic Transmission - drug effects</topic><topic>Time Factors</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murataeva, Natalia</creatorcontrib><creatorcontrib>Dhopeshwarkar, Amey</creatorcontrib><creatorcontrib>Yin, Danielle</creatorcontrib><creatorcontrib>Mitjavila, José</creatorcontrib><creatorcontrib>Bradshaw, Heather</creatorcontrib><creatorcontrib>Straiker, Alex</creatorcontrib><creatorcontrib>Mackie, Ken</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murataeva, Natalia</au><au>Dhopeshwarkar, Amey</au><au>Yin, Danielle</au><au>Mitjavila, José</au><au>Bradshaw, Heather</au><au>Straiker, Alex</au><au>Mackie, Ken</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>2016-08-01</date><risdate>2016</risdate><volume>110</volume><spage>173</spage><epage>180</epage><pages>173-180</pages><issn>1043-6618</issn><eissn>1096-1186</eissn><abstract>[Display omitted]
2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid in the brain and an agonist at two cannabinoid receptors (CB1 and CB2). The synthesis, degradation and signaling of 2-AG have been investigated in detail but its relationship to other endogenous monoacylglycerols has not been fully explored. Three congeners that have been isolated from the CNS are 2-linoleoylglycerol (2-LG), 2-oleoylglycerol (2-OG), and 2-palmitoylglycerol (2-PG). These lipids do not orthosterically bind to cannabinoid receptors but are reported to potentiate the activity of 2-AG, possibly through inhibition of 2-AG degradation. This phenomenon has been dubbed the ‘entourage effect’ and has been proposed to regulate synaptic activity of 2-AG. To clarify the activity of these congeners of 2-AG we tested them in neuronal and cell-based signaling assays.
The signaling profile for these compounds is inconsistent with an entourage effect. None of the compounds inhibited neurotransmission via CB1 in autaptic neurons. Interestingly, each failed to potentiate 2-AG-mediated depolarization-induced suppression of excitation (DSE), behaving instead as antagonists. Examining other signaling pathways we found that 2-OG interferes with agonist-induced CB1 internalization while 2-PG modestly internalizes CB1 receptors. However in tests of pERK, cAMP and arrestin recruitment, none of the acylglycerols altered CB1 signaling.
Our results suggest 1) that these compounds do not serve as entourage compounds under the conditions examined, and 2) that they may instead serve as functional antagonists. Our results suggest that the relationship between 2-AG and its congeners is more nuanced than previously appreciated.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>27117667</pmid><doi>10.1016/j.phrs.2016.04.015</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1043-6618 |
ispartof | Pharmacological research, 2016-08, Vol.110, p.173-180 |
issn | 1043-6618 1096-1186 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5108301 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | 2-AG 2-Arachidonoylglycerol 2-LG 2-Linolenoylglycerol 2-OG 2-Oleoylglycerol 2-Palmitoyglycerol 2-PG Acylglycerol Animals Arrestin - metabolism Cannabinoid Cannabinoid Receptor Antagonists - metabolism Cannabinoid Receptor Antagonists - pharmacology CB1 Cell Line Congener Cyclic AMP - metabolism Dose-Response Relationship, Drug Endocannabinoids - metabolism Endocannabinoids - pharmacology Entourage Extracellular Signal-Regulated MAP Kinases - metabolism Glycerides - metabolism Glycerides - pharmacology Hippocampus - cytology Hippocampus - drug effects Hippocampus - metabolism Humans Mice Neurons - drug effects Neurons - metabolism Phosphorylation Receptor, Cannabinoid, CB1 - antagonists & inhibitors Receptor, Cannabinoid, CB1 - genetics Receptor, Cannabinoid, CB1 - metabolism Synaptic Transmission - drug effects Time Factors Transfection |
title | Where’s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T17%3A11%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Where%E2%80%99s%20my%20entourage?%20The%20curious%20case%20of%202-oleoylglycerol,%202-linolenoylglycerol,%20and%202-palmitoylglycerol&rft.jtitle=Pharmacological%20research&rft.au=Murataeva,%20Natalia&rft.date=2016-08-01&rft.volume=110&rft.spage=173&rft.epage=180&rft.pages=173-180&rft.issn=1043-6618&rft.eissn=1096-1186&rft_id=info:doi/10.1016/j.phrs.2016.04.015&rft_dat=%3Cproquest_pubme%3E1798721288%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1798721288&rft_id=info:pmid/27117667&rft_els_id=S1043661816303346&rfr_iscdi=true |